# Liver Cancer

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/liver-cancer/

## Facts

| Field | Value |
| --- | --- |
| Open Access | true |
| ISSN-L | 1664-5553 |
| ISSNs | 1664-5553,2235-1795 |
| OpenAlex ID | https://openalex.org/S2764970739 |
| Publisher | Karger Publishers |

## Journal papers

- [Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)](https://scholariq.org/papers/guidelines-for-the-diagnosis-and-treatment-of-hepatocellular-carcinoma-2019/)
- [Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)](https://scholariq.org/papers/guidelines-for-diagnosis-and-treatment-of-primary-liver-cancer-in-china-2017/)
- [Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)](https://scholariq.org/papers/guidelines-for-the-diagnosis-and-treatment-of-primary-liver-cancer-2022-edition/)
- [A Radiomics Nomogram for Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma](https://scholariq.org/papers/a-radiomics-nomogram-for-preoperative-prediction-of-microvascular-invasion-in/)
- [From Cirrhosis to Hepatocellular Carcinoma: New Molecular Insights on Inflammation and Cellular Senescence](https://scholariq.org/papers/from-cirrhosis-to-hepatocellular-carcinoma-new-molecular-insights-on/)
- [Dual Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Inhibition Elicits Antitumor Immunity and Enhances Programmed Cell Death-1 Checkpoint Blockade in Hepatocellular Carcinoma](https://scholariq.org/papers/dual-vascular-endothelial-growth-factor-receptor-and-fibroblast-growth-factor/)
- [Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition)](https://scholariq.org/papers/guidelines-for-diagnosis-and-treatment-of-hepatocellular-carcinoma-with-portal/)
- [Systemic Therapy for Hepatocellular Carcinoma: Chinese Consensus-Based Interdisciplinary Expert Statements](https://scholariq.org/papers/systemic-therapy-for-hepatocellular-carcinoma-chinese-consensus-based/)
- [The Effectiveness of Multiple Electrode Radiofrequency Ablation in Patients with Hepatocellular Carcinoma with Lesions More than 3 cm in Size and Barcelona Clinic Liver Cancer Stage A to B2](https://scholariq.org/papers/the-effectiveness-of-multiple-electrode-radiofrequency-ablation-in-patients-with/)
- [Tumor Radiomic Features on Pretreatment MRI to Predict Response to Lenvatinib plus an Anti-PD-1 Antibody in Advanced Hepatocellular Carcinoma: A Multicenter Study](https://scholariq.org/papers/tumor-radiomic-features-on-pretreatment-mri-to-predict-response-to-lenvatinib/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.